Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131130 · ClinicalTrials.gov registry record · NA
Feasibility of a New Silicone Hydrogel Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01131130 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 120 participants.
The verdict
NCT01131130, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The objective of this study is to determine the product feasibility of the investigational contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft contact lenses.
Interventions
- DEVICE Air Optix Aqua
- DEVICE Acuvue Oasys Contact Lens
- DEVICE Investigational contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131130
The ClinicalTrials.gov registry entry for NCT01131130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Air Optix Aqua is the first listed.
NCT01131130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01131130 about?
NCT01131130 is a clinical study titled "Feasibility of a New Silicone Hydrogel Lens". The objective of this study is to determine the product feasibility of the investigational contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft contact lenses.
What is the current status of trial NCT01131130?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2010-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01131130?
The interventions under investigation include: Air Optix Aqua (DEVICE), Acuvue Oasys Contact Lens (DEVICE), Investigational contact lens (DEVICE).
Who is sponsoring clinical trial NCT01131130?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.